PSTG (PSTG) investor plans Rule 144 sale of 6,050 shares on NYSE

Rhea-AI Filing Summary

A holder of PSTG common stock filed a notice of proposed sale under Rule 144. The filing covers the potential sale of 6,050 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $408,072.50. The filing notes that there were 330,171,649 shares outstanding of this class of stock at the time of the notice, providing context for the size of the planned sale.

The seller acquired these 6,050 shares as performance shares from the issuer on 12/20/2025, with the same date shown as the date of payment and the nature of payment listed as not applicable. The section for securities sold during the past three months contains no data in this excerpt, and the representation language confirms the seller states they are not aware of undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6050	408072.50	330171649	12/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/20/2025	Performance Shares	Issuer			6050	12/20/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PSTG Form 144 filing disclose?

The filing discloses that a holder of PSTG common stock has notified the SEC of an intended sale of shares under Rule 144, including details on the number of shares, broker, market value, acquisition terms, and the stock exchange where the shares may be sold.

How many PSTG shares are proposed to be sold and on which exchange?

The notice covers a proposed sale of 6,050 common shares of PSTG on the NYSE, with Morgan Stanley Smith Barney LLC listed as the broker.

What is the aggregate market value of the PSTG shares in this Form 144?

The filing states an aggregate market value of $408,072.50 for the 6,050 PSTG common shares covered by the notice.

How many PSTG shares were outstanding at the time of this Form 144 notice?

The Rule 144 notice reports that there were 330,171,649 shares of the relevant class of PSTG common stock outstanding when the notice was prepared.

How and when were the PSTG shares in this Form 144 acquired?

The filing states that the 6,050 PSTG common shares were acquired as performance shares from the issuer on 12/20/2025, with the same date listed as the date of payment and the nature of payment noted as not applicable.

Does the PSTG Form 144 mention recent prior sales by the same holder?

The section requesting information on securities of the issuer sold during the past three months appears without populated entries in this excerpt, so no specific prior sales are listed here.

What representation does the seller make in the PSTG Rule 144 notice?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, as required by the form.